AzTrials
AzTrials

Early Childhood CariesNCT05260216

Clinical Analysis of a Risk-graded and Comprehensive Intervention for Early-childhood-caries

A study testing Comprehensive prevention and treatment and Routine prevention in people with Early Childhood Caries, run by Beijing Friendship Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cariogram and Cariostat will be used to assess the risk of caries in kindergarten children aged 3 years. Routine preventive measures will be taken for children at low risk of caries, and intensive intervention measures will be taken for children at medium and high risk. Read more about this study

Who is it for?
Ages 3 to 4 yearsHealthy volunteers can take part
Conditions the study is for
Early Childhood Caries
What is being tested?
Comprehensive prevention and treatment and Routine prevention
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
480 participants
Where
1 siteChina
Study dates
4 Nov 2021to 31 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 4 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Junior kindergarten children who enter the kindergarten in September 2021 and can cooperate with the oral health examination.
  • Parents of children fully understand the purpose of the study, cooperate with the questionnaire survey during the study, give informed consent and sign the informed consent form.
  • The child has no serious systemic diseases, has not taken hormones and immunosuppressants within 6 months, and has no history of antibiotic use within 1 month,and is not allergic to fluoride.

Who cannot join

  • Parents of children refuse to provide information about children's oral health or questionnaires.
  • Children cannot cooperate with oral health examination.
  • The child has a serious systemic disease that may affect the results of the study.
  • Children who are allergic to fluoride.

Trial locations and contacts

1 site in 1 country.

Menglin Cheng, Doctor contact

80838416

chengmenglin2011@126.com

China1 site, 1 recruiting
  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, 10000

    Menglin Cheng, Doctor, 80838416, chengmenglin2011@126.com

    Recruiting

Other trials in China

About this study

Official title: Clinical Analysis of Cariogram and Cariostat for Risk Assessment and Comprehensive Intervention of Early-childhood-caries

Cariogram and Cariostat will be used to assess the risk of caries in kindergarten children aged 3 years. Routine preventive measures will be taken for children at low risk of caries, and intensive intervention measures will be taken for children at medium and high risk. Routine measures will be taken for the control group. After one and two year, the prevalence of caries in the experimental group and the control group should be evaluated, and the cost-effectiveness evaluation will be conducted.

Read the detailed description

Caries risk-graded intervention for preschool children is needed as different child has different risk to suffer from caries.

Cariogram and Cariostat are two different and common caries risk assessment tools. Cariogram is a complicated but economical computer program which is more sensitive for caries risk assessment. Cariostat is a biological reagents with high specificity but it may be expensive to use for large numbers of children.

The experimental group will be divided into two subgroups, one use Cariogram and the other use Cariostat to assess the risk. Based on the results of the assessment, children with low risk of caries will get routine prevention including twice fluorinated foams each year and hygiene. Children with middle or high risk of caries will receive twice fluorinated varnish each year and professional caries treatment in addition to routine prevention.Routine prevention will be taken for the control group with both Cariogram and Cariostat assessment.

Follow-up will arrange one and two years after baseline recruitment. All participants will receive oral health-related questionnaires at baseline and follow-up.

The prevalence of caries in the experimental group and the control group should be evaluated, and the cost-effectiveness evaluation will be conducted.

Being tested
Comprehensive prevention and treatment, Routine prevention
Keywords
Caries risk assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Comprehensive prevention and treatmentCombination product

    Children with low risk of caries will receive routine prevention including fluoride foam application twice a year and oral hygiene guidance. Children with middle or high risk of caries will receive fluoride varnish application twice a year and caries restorative treatment in addition to routine prevention. The risk-graded intervention is one kind of comprehensive prevention and treatment.

  • Routine preventionCombination product

    Routine prevention includes fluoride foam application twice a year and oral hygiene guidance.

Study groups in NCT05260216
Study groupRoleWhat they receive
Experimental subgroup of CariostatExperimentalUse Cariostat as the caries risk assessment tool to divide the children into different risk levels. Based on the results, children with low risk of caries will receive twice fluoride foam each year and oral hygiene guidance, children with middle or high risk of caries will receive forth fluoride applications each year, oral hygiene guidance and professional caries treatment.
Receives: Combination Product: Comprehensive prevention and treatment
Experimental subgroup of CariogramExperimentalUse Cariogram as the caries risk assessment tool to divide the children into different risk levels. Based on the results, children with low risk of caries will receive twice fluoride foam each year and oral hygiene guidance, children with middle or high risk of caries will receive forth fluoride applications each year, oral hygiene guidance and professional caries treatment.
Receives: Combination Product: Comprehensive prevention and treatment
Control groupPlacebo comparatorUse Cariogram and as the caries risk assessment tool to divide the children into different risk levels. All children will receive routine prevention including wice fluoride foam each year and oral hygiene guidance.
Receives: Combination Product: Routine prevention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Decay teeth,Missed teeth and filled teeth (DMFT) and the change between different time points.

    The average value of the sum of the number of decayed teeth, the number of filled teeth, and the number of missed teeth due to caries.

    Measured: Baseline, one year follow up and two year follow up.

Secondary outcomes (1)
  1. Caries prevalence and the change between different time points.

    The proportion of population with caries in the whole participants.

    Measured: Baseline, one year follow up and two year follow up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2022
  2. Study start4 Nov 2021
  3. Primary completion31 Aug 2022 (estimated)
  4. Study completion31 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
480 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05260216
Sponsor's protocol ID
CARGACIFECC
Status last verified
Dec 2021
First submitted
12 Dec 2021
Last updated
21 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study protocol, statistical analysis plan, informed consent form and clinical study report are to be shared with other researchers.

Questions about this trial

What is this clinical trial studying?

A study testing Comprehensive prevention and treatment and Routine prevention in people with Early Childhood Caries, run by Beijing Friendship Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Menglin Cheng, Doctor (80838416, chengmenglin2011@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Decay teeth,Missed teeth and filled teeth (DMFT) and the change between different time points. (time frame: Baseline, one year follow up and two year follow up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in